Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L E Bird

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Biochemical Journal|November 15, 2002
Age-related changes in the composition, the molecular stoichiometry and the stability of proteoglycan aggregates extracted from human articular cartilageTerri Wells, Catherine Davidson, Matthias Mörgelin, et al.
The Journal of Pharmacy and Pharmacology|June 23, 2005
Bridging the gap: ageing, pharmacokinetics and pharmacodynamicsDominick G A Burton, Marcus C Allen, Joseph L E Bird, et al.
Molecular & General Genetics : MGG|September 1, 1993
The centromere and promoter factor, 1, CPF1, of Saccharomyces cerevisiae modulates gene activity through a family of factors including SPT21, RPD1 (SIN3), RPD3 and CCR4E A McKenzie, N A Kent, S J Dowell, et al.
The Journal of Biological Chemistry|May 9, 2000
Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bondingJ Ren, C Nichols, L E Bird, et al.
The EMBO Journal|October 6, 1997
Crystal structure of the site-specific recombinase, XerDH S Subramanya, L K Arciszewska, R A Baker, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2002
Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitorsJ Ren, L E Bird, P P Chamberlain, et al.
Experimental Gerontology|August 6, 2016
Absence of premature senescence in Werner's syndrome keratinocytesBadr Ibrahim, Angela N Sheerin, Katrin Jennert-Burston, et al.
The Journal of Biological Chemistry|February 22, 2000
Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analysesJ Ren, J Diprose, J Warren, et al.
Biogerontology|July 26, 2011
Recapitulation of Werner syndrome sensitivity to camptothecin by limited knockdown of the WRN helicase/exonucleaseJoseph L E Bird, Katrin C B Jennert-Burston, Marcus A Bachler, et al.
Atherosclerosis|January 9, 2010
Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosisJ L E Bird, D Izquierdo-Garcia, J R Davies, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Biochemical Journal|November 15, 2002
Age-related changes in the composition, the molecular stoichiometry and the stability of proteoglycan aggregates extracted from human articular cartilageTerri Wells, Catherine Davidson, Matthias Mörgelin, et al.
The Journal of Pharmacy and Pharmacology|June 23, 2005
Bridging the gap: ageing, pharmacokinetics and pharmacodynamicsDominick G A Burton, Marcus C Allen, Joseph L E Bird, et al.
Molecular & General Genetics : MGG|September 1, 1993
The centromere and promoter factor, 1, CPF1, of Saccharomyces cerevisiae modulates gene activity through a family of factors including SPT21, RPD1 (SIN3), RPD3 and CCR4E A McKenzie, N A Kent, S J Dowell, et al.
The Journal of Biological Chemistry|May 9, 2000
Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bondingJ Ren, C Nichols, L E Bird, et al.
The EMBO Journal|October 6, 1997
Crystal structure of the site-specific recombinase, XerDH S Subramanya, L K Arciszewska, R A Baker, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2002
Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitorsJ Ren, L E Bird, P P Chamberlain, et al.
Experimental Gerontology|August 6, 2016
Absence of premature senescence in Werner's syndrome keratinocytesBadr Ibrahim, Angela N Sheerin, Katrin Jennert-Burston, et al.
The Journal of Biological Chemistry|February 22, 2000
Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analysesJ Ren, J Diprose, J Warren, et al.
Biogerontology|July 26, 2011
Recapitulation of Werner syndrome sensitivity to camptothecin by limited knockdown of the WRN helicase/exonucleaseJoseph L E Bird, Katrin C B Jennert-Burston, Marcus A Bachler, et al.
Atherosclerosis|January 9, 2010
Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosisJ L E Bird, D Izquierdo-Garcia, J R Davies, et al.
Pageof 3